CVM Technical Unit Recommends No Mandatory OPA for Oncoclínicas

Overview

• The CVM’s Superintendência de Registro de Valores Mobiliários recommended on Tuesday that a statutory Offer for Acquisition (OPA) not be required in Oncoclínicas.
• The technical unit said a corporate-reorganization exception in paragraph 8 of article 39 of the company’s bylaws applies and cited evidence that Centaurus held an indirect stake above 15 percent since 2018.
• Centaurus argued it did not become a new shareholder in 2024 because its relevant ownership predated the IPO, and Oncoclínicas said it only disclosed information provided by shareholders and was not obliged to probe private investor arrangements.
• Minority investors including Latache and Abraicc pushed for a mandatory OPA and retain the right to challenge the technical ruling through administrative or judicial appeal.
• Lawyers and market observers noted the case moved more slowly than similar CVM reviews and said the outcome could affect how the regulator treats indirect holdings and minority-protection clauses going forward.